Yu Yong 4
4 · GENELUX Corp · Filed Jun 18, 2026
Research Summary
AI-generated summary of this filing
GENELUX (GNLX) CSO Yu Yong Receives 119,318 RSU Award
What Happened
- Yu Yong, Chief Scientific Officer of GENELUX Corp (GNLX), was granted 119,318 restricted stock units (RSUs) on June 16, 2026. The Form 4 reports an acquisition price of $0 because these are compensation awards that convert to shares only upon vesting. This transaction is an award (not a purchase or sale).
Key Details
- Transaction date: 2026-06-16; Form 4 filed 2026-06-18 (timely filing).
- Transaction type/code: A — Grant/Award of RSUs.
- Shares involved: 119,318 RSUs; reported acquisition price: $0.
- Vesting/footnote: Per footnote F1, RSUs vest 25% on the first anniversary of the grant, then the remainder vests in 12 equal quarterly installments thereafter.
- Shares owned after transaction: not specified in the provided filing details.
- No 10b5-1 plan, tax-withholding sale, or immediate cash exercise reported.
Context
- RSUs are a form of equity compensation that convert to common stock only after vesting; they do not represent immediate stock purchases or sales. Grants are common for executive pay and do not necessarily signal a buy/sell view by the insider.
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Yu Yong
Chief Scientific Officer
Transactions
- Award
Common Stock
[F1]2026-06-16+119,318→ 269,024 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter.
Signature
/s/ Thomas Zindrick, Attorney-in-Fact|2026-06-18